About this trial
The purpose of this randomized controlled trial is to evaluate whether the InMotion intervention, delivered via telehealth (using a HIPAA-compliant video platform or phone), which uses evidence-based behavioral and motivational counseling to increase daily physical activity, is an effective treatment for Major Depressive Disorder (MDD) for people who are at least one year out from sustaining a traumatic brain injury (TBI). The first aim is to compare the efficacy of the InMotion intervention to the waitlist control (WLC) condition on measures of depression severity and associated conditions in under-active adults with TBI and MDD. For the second aim the investigators plan to identify possible moderators of exercise treatment effects. The third aim will examine possible mediators of treatment outcome. In addition, the weekly dose of exercise, the extent to which exercise generates positive affect, and engagement in enjoyable or meaningful aspects of life will be explored.
Eligibility criteria
Qualifiers
Enrollment in the Traumatic Brain Injury Model System (TBIMS) from one of the six referring centers.
Must be between 18-64 years of age at the time of enrollment.
Must have cognitive capacity to consent.
Must be >1 year out from the date of the Traumatic Brain Injury.
Disqualifiers
We will exclude people with active suicidal intent or plan or other severe psychiatric conditions (bipolar disorder, schizophrenia, psychosis, any schizoaffective disorder).
We will exclude people with current substance use disorder (excluding tobacco) because they require intensive treatment, specifically people who report having > 5 drinks for men or >4 for women on a single occasion AND have >14 drinks for males / > 7 drinks per week for females per week. These questions are an existing part of the Traumatic Brain Injury Model System, Form II follow-up interview and participant exclusion for this will take place as part of that study.
We will exclude people for drug dependence as defined within the Mini International Neuropsychiatric Interview (MINI).
We will exclude people not fluent in English.
Trial design
Treatments tested in this trial
- InMotion
Treatment groups
Sponsors and collaborators
University of Washington
Lead sponsor
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator